SKB BIO-B(06990) completes full circulation of H-shares

SKB BIO-B(06990) announced that the company has received a record notice from the China Securities Regulatory Commission on the implementation of full circulation of H shares, with the date set for August 23, 2024. The company's total of 1,157,800 domestic and non-listed foreign shares have been approved for full circulation of H shares. Additionally, the company received approval from the Hong Kong Stock Exchange on September 3, 2024 for the conversion of H shares and permission to trade. The conversion of H shares was completed on September 17, 2024, and trading of H shares will begin on the Hong Kong Stock Exchange at 9:00 a.m. on September 19, 2024.